Expansion of the Pharmaceutical and Other Product Pipeline Through In-House, In-Licensed and Joint Development

A theme focused on building a pipeline of diagnostic products, medical devices and regenerative medicine-related products, primarily for central nervous system diseases, by combining in-house development, in-licensed development and joint development, and taking these products through regulatory approval and launch.